EL.En. S.p.A. Stock OTC Markets

Equities

ELEAF

IT0005453250

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 10:53:27 2024-02-01 EST 5-day change 1st Jan Change
9.8 USD +1.87% Intraday chart for EL.En. S.p.A. -.--% -22.14%

Financials

Sales 2024 * 717M 774M 1.07B Sales 2025 * 762M 823M 1.13B Capitalization 792M 856M 1.18B
Net income 2024 * 51M 55.08M 75.81M Net income 2025 * 59M 63.72M 87.7M EV / Sales 2024 * 1.01 x
Net cash position 2024 * 69.09M 74.62M 103M Net cash position 2025 * 107M 116M 159M EV / Sales 2025 * 0.9 x
P/E ratio 2024 *
14.9 x
P/E ratio 2025 *
13.3 x
Employees -
Yield 2024 *
2.53%
Yield 2025 *
2.53%
Free-Float 56.8%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.87%
6 months-22.14%
Current year-22.14%
More quotes
Current year
9.62
Extreme 9.62
10.24
1 year
9.62
Extreme 9.62
10.24
3 years
9.62
Extreme 9.62
16.13
5 years
9.62
Extreme 9.62
41.66
10 years
9.62
Extreme 9.62
41.66
More quotes
Managers TitleAgeSince
Founder 84 81-03-31
Chief Executive Officer 58 91-12-31
Chief Executive Officer 72 81-03-31
Members of the board TitleAgeSince
Chief Executive Officer 72 81-03-31
Founder 84 81-03-31
Chief Executive Officer 58 91-12-31
More insiders
El En SpA is an Italy-based company primarily engaged in the production of laser systems. It controls a group of companies active in the manufacture, research, development, distribution and sale of laser equipment.The Company's range of products includes laser systems for dermatology, surgery, cosmetics, physiotherapy, dentistry and gynaecology, laser systems for cutting, marking and welding of metals, wood, plastic and glass; decoration of leather and fabrics, conservative restoration of works of art. The Company also offers accessories, after-sale services and consulting in the related areas.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
9.9 EUR
Average target price
12.03 EUR
Spread / Average Target
+21.55%
Consensus

Quarterly revenue - Rate of surprise